midostaurin for newly diagnosed flt3 aml: radius-x efficacy and safety data
Published 5 years ago • 338 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
3:12
go plus midostaurin and intensive chemotherapy in cbf and flt-mut aml
-
3:56
radius results: midostaurin reduces relapse after asct in flt3-itd aml
-
2:08
comparing midostaurin to next-generation flt3 inhibitors in the frontline treatment of flt3-itd aml
-
0:59
midostaurin: a step forward in the treatment of flt3-mutated aml
-
3:42
midostaurin in c-kit or flt3-itd mutated t(8;21) aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
2:40
what we still don't know about the ratify study of midostaurin in aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
1:52
the management of r/r flt3-mutated aml
-
2:40
an overview of the safety profile of flt3 inhibitors in aml
-
1:58
efficacy of first generation flt3 inhibitors for aml
-
1:59
tangible benefit for flt3-itd r/r aml on quizartinib
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
1:30
combinations with flt3 inhibitors: the way forward for aml treatment
-
6:30
flt3-mutated aml: midostaurin and chemotherapy